Cite
HARVARD Citation
Ogawa, H. et al. (2020). DLL3 expression is a predictive marker of sensitivity to adjuvant chemotherapy for pulmonary LCNEC. Thoracic cancer. 11 (9), pp. 2561-2569. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ogawa, H. et al. (2020). DLL3 expression is a predictive marker of sensitivity to adjuvant chemotherapy for pulmonary LCNEC. Thoracic cancer. 11 (9), pp. 2561-2569. [Online].